Scott B. Brown

Scott B. Brown is a declared insider of Tracon Pharmaceuticals, Inc. (finance chief), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 22 January 2020 and the latest from 20 April 2023.

No open-market sale appears; the market trades are 5 purchases worth €23k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.

Half of the purchases are above €4,906 and half below. Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 13 March 2024, reports a share grant of €439 in Tracon Pharmaceuticals, Inc. The last insider purchase was made public on 3 January 2023, 1,389 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.